1. Academic Validation
  2. Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity

Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity

  • J Med Chem. 2019 Nov 14;62(21):9658-9679. doi: 10.1021/acs.jmedchem.9b01085.
Anna S Pirzer 1 Roman Lasch 1 Heike Friedrich 1 Harald Hübner 1 Peter Gmeiner 1 Markus R Heinrich 1
Affiliations

Affiliation

  • 1 Department of Chemistry and Pharmacy, Medicinal Chemistry , Friedrich-Alexander-Universität Erlangen-Nürnberg , Nikolaus-Fiebiger-Str. 10 , 91058 Erlangen , Germany.
Abstract

Many subtype-selective Dopamine Receptor ligands developed for the D2-D4 family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying an extended binding pocket (EBP) of the receptor via an aliphatic linker of variable lengths. The evaluation of a novel group of Dopamine Receptor ligands now showed that highly subtype-selective ligands [up to Ki(D4.4) = 0.25 nM, D2L/D4.4 = 320, D3/D4.4 = 710 for APH199 (17)] can be obtained by choosing a relatively large and conformationally flexible 1-benzyl-1-phenylsemicarbazide substructure to fill the EBP. The novel chemotype APH199 (17) was found to act as a full agonist at the D4 receptor showing significant bias toward G protein activation over β-arrestin recruitment in comparison to quinpirole.

Figures